Reinforcing its commitment to making advanced Cancer Care more accessible and patient-centric, ShardaCare-Healthcity, the largest super speciality hospital in Greater Noida, has announced a significant strengthening of its Oncology programme, establishing Greater Noida’s first complete Cancer Care Center, with the onboarding of four senior specialists across Surgical and Medical Oncology.
The expansion includes the appointment of Dr Malay Nandy as Senior Director & Head, Medical Oncology; Dr Parveen Mendiratta as Director & Unit Head, Surgical Oncology; Dr Sanjeev Kumar Tuli as Associate Director, Surgical Oncology, and Dr Ruchir Tandon as Senior Consultant, Medical Oncology.
The team is supported by a highly trained nursing and clinical support staff, collectively forming a comprehensive, patient-focused oncology unit equipped to manage a wide spectrum of cancer cases.
Cancer incidence is witnessing a steady rise in India, making it a major public health concern. According to GLOBOCAN 2022, the country reported over 1.46 million new cases, with a projected 12–15% increase by 2030. Cancer-related mortality remains high at over 850,000 deaths annually, largely due to late diagnosis, limited awareness, and restricted access to specialised care.
In response to these challenges, ShardaCare-Healthcity’s strengthened oncology programme bridges gaps between rising case volumes and access to coordinated, high-quality care by integrating medical, surgical, and radiation oncology within a single ecosystem.The programme offers chemotherapy, immunotherapy, targeted and endocrine therapy, personalised plans, daycare and regional chemotherapy; minimally invasive, robotic and laparoscopic surgeries, organ-specific resections, and reconstructive procedures; along with advanced radiotherapy including IMRT, IGRT, VMAT, stereotactic radiosurgery, brachytherapy, and precision image-guided treatments, enabling highly targeted and effective care under one roof.